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Fig. 1. The groups of drugs that produce 
most commonly adverse reactions
According to the World Health Organization, pharmacovigilance is the science that
deals with the detection, evaluation and prevention of adverse drug reactions. 
Increased interest in adverse reaction research continues to be the topical issue of the
studies for reducing their incidence. 
In order to prevent and reduce the risk of adverse drug reactions and to improve the public 
health system, mechanisms for monitoring and evaluating the safety of medicines in medical 
practice are vital. This implies the existence of a well-organized pharmacovigilance system, 
pharmacovigilance being the key element in the medical offices and in the public health
program.
The evaluation of the
collection, management and
monitoring of adverse 
reactions in the
pharmacovigilance activity.
The communication sheets of the adverse reactions received by the
Pharmacovigilance Departement within the Medicines and Medical Devices Agency 
during the period from 2018 to 2019 were researched and evaluated. 
All communication sheets (93 sheets) - were received, analyzed, recorded in the
database of adverse drug reactions and other suspected pharmaceutical products.
During the period from 2018 to 2019, 93 sheets of communication of adverse reactions
were analyzed, among which 12 cases of inefficiency of the drug preparation. According
to the data obtained regarding the group of patients we had examined there is a 
predominance of women vs. men (55% and 60%), which corresponds to the data of the
researched literature. The predominant age is suitable for work: 30-50 years, with a 
share of 46% specific for both groups studied. 
Based on the obtained data, we found that it was a higher incidence of oral drugs
administration (62%) and the predominance of solid pharmaceutical forms (tablets-36%, 
capsules-8%, powder-3%). 
The most commonly reported adverse reactions were of the following groups of drugs: 
antituberculosis drugs–85%, antibiotics–48^, perfusion solutions–22%, nonsteroidal
anti¬inflammatory drugs -18%, contrast agents– 15%, antiretrovirals– 11%.
The importance of avoiding and detecting adverse
reactions is a goal of the future, which requires
everyone's contribution to solving it, through the
receptivity of reports, the active encouragement of

























Fig. 2. Countries producing drugs that 
have caused adverse effects
